Early Biologic Initiation Linked to Rapid Improvement of JIA
The findings have implications for insurance rules that require patients to take a DMARD for a minimum period before initiating biologic therapy.
Source: medscape.com
Biologic First News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Biologic First. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Biologic First Today - Breaking & Trending Today
Concomitant Initiation of csDMARDs and bDMARDs Increases Remission Rates in JIA
A total of 297 patients with pediatric juvenile idiopathic arthritis who had a 3-year visit, were included in the study.
Source: empr.com
Early combination treatment achieves clinically inactive disease in children with polyarticular JIA
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, found that patients started on early, aggressive treatment with a combination of biologic and conventional disease modifying antirheumatic drugs (DMARDs) achieved clinically inactive disease in children with polyarticular juvenile idiopathic arthritis (JIA) more frequently compared to other treatment plans 24 months after starting treatment.
Source: news-medical.net